News
The European Commission has approved Sanofi’s Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) ...
Simtra BioPharma Solutions has purchased a 65-acre property with more than 300,000 square feet of available space for ...
AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...
Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet ...
Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish ...
Abzena, an end-to-end integrated CDMO and CRO, has appointed Geoffrey M. Glass as Chief Executive Officer (CEO), effective ...
Operational strategies to optimize efficiency and cost effectiveness, and secure an unbroken chain of custody from ...
Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) ...
Cycle Pharmaceuticals has awarded LeMed Specialty Pharmacy the exclusive contract for specialty pharmacy distribution and ...
Vicebio Ltd, a biopharmaceutical company developing novel vaccines, has entered an exclusive, definitive agreement to be ...
Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.
Sygnature Discovery has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results